1994
DOI: 10.1007/bf02260521
|View full text |Cite
|
Sign up to set email alerts
|

Superwarfarin poisoning: A significant public health problem

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
20
0

Year Published

2000
2000
2018
2018

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(21 citation statements)
references
References 26 publications
1
20
0
Order By: Relevance
“…However, absorption through the skin can occur, and a number of cases with an unknown origin have been encountered. [6][7][8][9] Here, we report a case of brodifacoum intoxication with no identified route, which was confirmed by the detection of brodifacoum in serum. …”
Section: Introductionmentioning
confidence: 70%
“…However, absorption through the skin can occur, and a number of cases with an unknown origin have been encountered. [6][7][8][9] Here, we report a case of brodifacoum intoxication with no identified route, which was confirmed by the detection of brodifacoum in serum. …”
Section: Introductionmentioning
confidence: 70%
“…The capability of terrorists to use these commercially available poisons depends upon the availability of large amounts of high-concentration product (whether obtained legally or illegally), the target population and its vulnerability, and the method of effective delivery and dissemination (EPA, 2005;WHO, 2008). Although these anticoagulants may be absorbed through the skin and lungs, the main route of exposure is ingesting food or water containing the product (Jones et al, 1984;Katona and Wason, 1989;Swigar et al, 1990;Wallace et al, 1990;Exner et al, 1992;Rauch et al, 1994;Gallo, 1998;Corke, 1997). Superwarfarin poisoning may result in a large number of casualties if these substances are ingested (Palmer et al, 1999;Baker et al, 2002;EPA, 2005;POISINDEX, 2007;HSDB, 2008).…”
Section: Introductionmentioning
confidence: 95%
“…Newer long-acting warfarin derivatives such as brodifacoum, bromadiolone, diphenadione, and chlorophacinone can produce profound and prolonged anticoagulation and bleeding after a latency period that generally lasts 24-72 h FDA, 1985;Chong et al, 1986;Greeff et al, 1987;Smolinske et al, 1989;Swigar et al, 1990;Wallace et al, 1990;Routh et al, 1991;Wilton, 1991;Exner et al, 1992;Rauch et al, 1994;IPCS, 1995a-e;Hui et al, 1996;Tecimer and Yam, 1997;Chua and Friedenberg, 1998;Gallo, 1998;EPA, 2003EPA, , 2005 (Table 18.1).…”
Section: Introductionmentioning
confidence: 97%
See 1 more Smart Citation
“…[3,4] Due to their high-lipid solubility, increased affinity for hepatic enzymes, and significant increase in potency as well as their ability to overcome resistance, LAARs earned the moniker "superwarfarin", which continues in use today. [5][6][7][8] LAARs induce anticoagulation through inhibition of the Vitamin K Epoxide Reductase enzyme. [1] This inhibition leads to reduced ability to gamma-carboxylate terminal glutamine residues of Vitamin K Dependent coagulation factors.…”
Section: Introductionmentioning
confidence: 99%